Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
2.08
↓ 99% below average
Average (5y)
398.04
Historical baseline
Range
High:1552.14
Low:0.00
CAGR
-69.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.08 | -3.6% |
| 2023 | 2.16 | -98.0% |
| 2022 | 108.02 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 1552.14 | +114.4% |
| 2019 | 723.85 | - |